Improved postmarketing surveillance system may reduce the number of adverse reactions to prescription drugs that under the current system continue to rise as the number of prescriptions written in the U.S. rises.
This web page is marked up with Schema.org microdata. Much of the necessary microdata is embedded within the HTML that creates the display you see above. The data that shows below is formatted for machine-reading and rounds out the complete descriptive set for this resource. Want more info about all of this? Go here. You can also view the complete dataset for this resource the way a machine sees it here .
Title: Improving Drug Safety: The Importance of Postmarking Drug Surveillance
Publication date 2004-12-01
Publication Year 2004
Robert N. Butler
, James Nyberg
International Longevity Center-USA
, drug safety
, clinical trials
Resource provided by IssueLab